Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study.
OBJECTIVE
To evaluate the relation between apathy and development of dementia in patients with amnestic mild cognitive impairment (MCI).


METHODS
Two hundred and fifty-one French-speaking outpatients fulfilling the criteria of amnestic MCI were enrolled. Apathy was assessed with the Apathy Inventory (IA). Neuropsychiatric evaluation also included the Goldberg anxiety scale and the Montgomery and Asberg Depressive Rating Scale (MADRS). The main end point considered after a 1-year follow-up was the development of dementia of Alzheimer type (DAT).


RESULTS
At baseline there were 86 (39.8%) subjects presenting at least one symptom of apathy among the 216 included in analysis. After a 1-year follow-up, 22 patients developed DAT. Of the patients with apathy at baseline 13 (15.1%) developed DAT in comparison with 9 (6.9%) of the non-apathetic patients. At the 1-year follow-up, patients developing DAT had a significantly higher frequency of apathetic symptoms (91.7%) than patients without DAT (26.9%).


CONCLUSIONS
Taking into account that apathy is one of the most frequently observed neuropsychiatric symptoms in MCI and in DAT the present study suggests that patients with MCI and apathy should be more closely observed.
Robert
Philippe H
PH
Centre Mémoire de Ressources et de Recherche, CHU de Nice, INSERM JE 2441, France. philippe.robert15@wanadoo.fr
Berr
Claudine
C
Volteau
Magali
M
Bertogliati
Christelle
C
Benoit
Michel
M
Sarazin
M
M
Legrain
Sylvie
S
Dubois
Bruno
B
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D000647:Amnesia / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D003072:Cognition Disorders / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D009042:Motivation; D009483:Neuropsychological Tests; D012307:Risk Factors